GL1X · GenesisL1 explorer

MolNFT v1 · #10324 · protein

A sialic acid derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies

1INW · Influenza a subtype N2 neuraminidase: “A sialic acid derived phosphonate analog inhibits different strains of influenza virus neuraminidase with…”. X-ray diffraction, 4 ligands (AXP, NAG, MAN), 1 pocket (best druggability 0.62).…

PDB
1INW
Type
protein
Length
388 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Influenza a subtype N2 neuraminidase
EC
3.2.1.18
UniProt
P06820
Ligands
AXP, NAG, MAN, CA
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInfluenza a subtype N2 neuraminidase (EC 3.2.1.18)protein3883% helix, 48% strandP06820

Ligands and binding sites

  • AXP · (1S)-4-acetamido-1,5-anhydro-2,4-dideoxy-1-phosphono-D-glycero-D-galacto-octitol · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 3 copies
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13220.620.7940AXP

Modifications

Observed in the structure: 9 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 1INW · A sialic acid derived phosphonate analog inhibits different strains of influenza virus… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.